Publikation

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.

Wissenschaftlicher Artikel/Review - 09.07.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner P, Buetikofer L, Mordasini P, Deppeler S, Mendes Pereira V, Albucher J, Darcourt J, Bourcier R, Guillon B, Papagiannaki C, Ozkul-Wermester O, Sibolt G, Tiainen M, Gory B, Richard S, Liman J, Ernst M, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Lapergue B, Ribó M, Tomasello A, Saleme S, Macian F, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Hernández-Pérez M, Pop R, Della Schiava L, Luft A, Piotin M, Gentric J, Pikula A, Pfeilschifter W, Arnold M, Siddiqui A, Froehler M, Furlan A, Chapot R, Wiesmann M, Machi P, Diener H, Kulcsar Z, Bonati L, Bassetti C, Mazighi M, Liebeskind D, Saver J, Gralla J, SWIFT DIRECT Collaborators. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet 2022; 400:104-115.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Lancet 2022; 400
Veröffentlichungsdatum
09.07.2022
eISSN (Online)
1474-547X
Seiten
104-115
Kurzbeschreibung/Zielsetzung

Whether thrombectomy alone is equally as effective as intravenous alteplase plus thrombectomy remains controversial. We aimed to determine whether thrombectomy alone would be non-inferior to intravenous alteplase plus thrombectomy in patients presenting with acute ischaemic stroke.